Status epilepticus is a rare and dangerous condition where seizures go on for too long or happen one after another without stopping. It has been estimated that up to 150,000 cases of status epilepticus occur annually in the U.S.
The company we are profiling today is Marinus Pharmaceuticals Inc. (MRNS), which is investigating the potential of its lead drug candidate IV Ganaxolone for patients with status epilepticus.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.